Statement About MMT from NIDDK

From NIDDK Fact Sheet

Chronic Hepatitis C: Current Disease Management

“Strict abstinence from alcohol is recommended during therapy with interferon. Interferon therapy can be associated with relapse in people with a previous history of drug or alcohol abuse. Therefore, alpha interferon should be given with caution to a patient who has only recently stopped alcohol or substance abuse. Typically a 6-month abstinence is recommended before starting therapy, but this should be applied only to patients with a history of alcohol abuse, not to social drinkers. Patients with continuing alcohol or substance abuse problems should only be treated in collaboration with alcohol or substance abuse specialists or counselors. Patients can be successfully treated while on methadone or in an active substance abuse program. Indeed, the rigor and regular monitoring that accompany methadone treatment provide a structured format for combination therapy. The dose of methadone may need to be modified during interferon-based therapy for hepatitis.”

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is part of the National Institutes of Health under the U.S. Department of Health and Human Services.

From: NIH Publication No. 03-4230 February 2003

Similar Posts

  • Category: AATOD

    Admin 12/26/2021

    Congratulations to Sara Gefvert, the 2022 Lane/Holden Award Winner! November 2, 2022 The 2022 Richard Lane/Robert Holden Patient Advocacy Award was presented at an Awards Reception held in conjunction with the 2022 Conference of the American Association for the Treatment of Opioid Dependence (AATOD) in Baltimore, Maryland on November 2, 2022. Richard Lane/Robert Holden Patient…

  • Frameset for Methadone Treatment Discussion

    Admin 01/05/2022

    WELCOME TO “METHADONE SPOKEN HERE” NAMA’s NEW Web Discussion Forum Home This is an on-line discussion forum called Methadone Spoken Here.   The contents frame shows the titles of all articles posted to the discussion. Selecting a title will cause the corresponding article to be loaded into this frame. You may also: Post a new article…

  • Drug Court Fact Sheet

    Admin 01/29/2022

    Methadone Maintenance and Other Pharmacotherapeutic Interventions in the Treatment of Opioid Dependence. Overview Drug Courts are being confronted with increasing numbers of opiate dependent offenders. This Fact Sheet is intended to dispel misperceptions and educate practitioners about the efficacy of medication assisted treatment. Opioid dependence is a devastating reality and a treatable disease. According to…

  • The Methadone Awareness Test

    Admin 05/08/2022

    How much do you really know about methadone? Take NAMA’s Methadone Awareness Test and find out! Most Frequently Asked Question: Is methadone maintenance “trading one addiction for another”     Answer Pregnant women should withdraw or at least lower their dose of methadone so that the baby is not born dependent. True or false?   Answer Methadone…

  • NAMA Policy Statement: On the Name of Methadone Anonymous

    Admin 07/25/2021

    NAMA is well aware of the importance Methadone Anonymous has had on patients across the United States. Organizing a 12 step group is hard work and the commitment of Methadone Anonymous to the recovery of methadone patients is apparent. Methadone Anonymous contends with the same discrimination and stigma that NAMA has battled with. We believe…

  • The President’s Office

    Admin 08/17/2022

    Methadone treatment is entering a new era giving methadone patients opportunities that they never had before. Our views and issues are being taken seriously by many and it is important that advocacy organizations continue their important role as the patient’s voice. It is because of the hard work of many of the NAMA chapters that…